Literature DB >> 19527455

The development of immune responses in Balb/c mice following inoculation with attenuated or virulent Neospora caninum tachyzoites.

P M Bartley1, S E Wright, S W Maley, D Buxton, M Nath, E A Innes.   

Abstract

Balb/c mice were inoculated intraperitoneally (i.p.) with either 5 x 10(6) live virulent (group 1) or 5 x 10(6) live attenuated (group 2) tachyzoites, or Vero cells (group 3). Animals were killed at 0, 14, 28 and 42 days post-inoculation (p.i.), with the remaining mice receiving a lethal challenge on day 48 p.i. Serum, spleen and brain samples were collected post-mortem to examine humoral and cell-mediated immune responses as well as pathological lesions and to quantify parasite loads. On day 14 p.i. group 2 (attenuated) demonstrated statistically significant (P < 0.001) lower levels of mean morbidity and weight loss, while also showing significantly (P = 0.01) higher levels of splenocyte proliferation and IFN-gamma production (P = 0.003), compared to group 1 (virulent). Histology of brain samples showed milder lesions and a lower incidence of positive immunohistochemistry, demonstrating tachyzoites and tissue cysts, and statistically significant (P = 0.03) lower mean burdens of parasite DNA in group 2 (attenuated) compared to group 1 (virulent). All mice in group 2 were protected following challenge on day 48 p.i. whereas naïve control mice succumbed to the challenge. No mice from group 1 (virulent) survived beyond day 24 p.i. so they were not included in the challenge.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527455     DOI: 10.1111/j.1365-3024.2009.01115.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  3 in total

1.  Protection against lethal Neospora caninum infection in mice induced by heterologous vaccination with a mic1 mic3 knockout Toxoplasma gondii strain.

Authors:  Diana Marcela Penarete-Vargas; Marie Noelle Mévélec; Sarah Dion; Edouard Sèche; Isabelle Dimier-Poisson; Thierry Fandeur
Journal:  Infect Immun       Date:  2009-12-07       Impact factor: 3.441

2.  Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model.

Authors:  Thierry Monney; Denis Grandgirard; Stephen L Leib; Andrew Hemphill
Journal:  Pathogens       Date:  2013-03-27

3.  Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice.

Authors:  Silvia Rojo-Montejo; Esther Collantes-Fernández; Inmaculada López-Pérez; Verónica Risco-Castillo; Antoni Prenafeta; Luis Miguel Ortega-Mora
Journal:  Vet Res       Date:  2012-08-22       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.